A 24-week double-blind placebo-controlled study of the efficacy and safety of the AMPA modulator S47445 in patients with mild to moderate Alzheimer’s disease and depressive symptoms
Bernard K, Gouttefangeas S, Bretin S, Galtier S, Robert P, Holthoff-Detto V
